Investigators saw more deaths in patients with severe TR after repeat mitral valve procedures; what to do about it is unclear ...

Aims Pulmonary hypertension (PHT) appears to be very common in heart failure with preserved ejection fraction but details on ...

Association of Tricuspid Regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip system: 30‐day and 12‐month follow‐up from the GRASP ...

Degenerative mitral valve disease is common. Up to a quarter of patients with degenerative mitral valve disease may be asymptomatic despite having severe valve regurgitation. Current guideline ...

Highlighted text has been updated as of November 13, 2024. The MATTERHORN trial showed that M-TEER is noninferior to surgical mitral valve repair regarding clinical efficacy and has a better safety ...

Introduction: Fabry disease, caused by mutations in the gene encoding alpha-galactosidase A, results in the accumulation of globotriaosylceramide (Gb3), leading to systemic complications including ...

Echo parameters: The beneficial effect of transcatheter mitral valve replacement compared with GDMT alone was consistent in all echocardiographic subgroups, independent of the severity of LV ...

Secondary mitral regurgitation (SMR) is a complex and evolving challenge in the landscape of ... Or should we adopt an integrated approach, incorporating early mitral valve intervention, especially ...

For patients with symptomatic and severe or greater tricuspid regurgitation (TR), transcatheter tricuspid valve replacement (TTVR) plus optimal medical therapy (OMT) yields substantial improvement ...